Effectiveness and tolerability of Perindopril plus Amlodipine single pill combination in Nigeria: The 13 City Hypertension Study

Dike B Ojji, V. Ansa, B. M. Ale, M. Sani, Austine Obasahan, Sola Alagbe, Rotimi Williams, Tony Aknitomide, I. Okoye, E. Umuerri, Eze Nwafor, A. Mbakwem, C. Amadi, Lamkur Shedu, Ranti Familoni, T. Olunuga, Francisca Inofomoh, U. Osuji, Godwin Omejua, Benjamin Azubuike, E. Ohihoin, Raphael Anakwe
{"title":"Effectiveness and tolerability of Perindopril plus Amlodipine single pill combination in Nigeria: The 13 City Hypertension Study","authors":"Dike B Ojji, V. Ansa, B. M. Ale, M. Sani, Austine Obasahan, Sola Alagbe, Rotimi Williams, Tony Aknitomide, I. Okoye, E. Umuerri, Eze Nwafor, A. Mbakwem, C. Amadi, Lamkur Shedu, Ranti Familoni, T. Olunuga, Francisca Inofomoh, U. Osuji, Godwin Omejua, Benjamin Azubuike, E. Ohihoin, Raphael Anakwe","doi":"10.24170/19-1-5357","DOIUrl":null,"url":null,"abstract":"Background: There is no large-scale study that has shown the efficacy of single pill combination (SPC) antihypertensive medications in black African population. We therefore evaluated the blood pressure (BP) lowering efficacy and the tolerability of Perindopril plus Amlodipine SPC in black African patients. Methods: It was a multi-centre, prospective, observational programme among hypertensive patients using different doses of Perindopril and Amlodipine. Primary endpoint was assessed as the change in mean sitting systolic and diastolic BPs from baseline to 3 months. Results: 937 patients (55.7% female) were analysed, and the mean age was 56.4 ± 12.7 years. Systolic and diastolic BPs were significantly reduced by 17.3/ 9.4mmHg, 21.1/10.8mmHg mmHg and 24.6/12.7mmHg at 4, 8 and 12 weeks respectively compared to baseline value (p<0.0001). Dry cough was seen in 0.64% and angioedema 0.1% of the patients. Conclusions: Perindopril plus Amlodipine SPC provided clinically meaningful BP reductions and is well tolerated in a black African population.","PeriodicalId":55781,"journal":{"name":"SA Heart Journal","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"SA Heart Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24170/19-1-5357","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: There is no large-scale study that has shown the efficacy of single pill combination (SPC) antihypertensive medications in black African population. We therefore evaluated the blood pressure (BP) lowering efficacy and the tolerability of Perindopril plus Amlodipine SPC in black African patients. Methods: It was a multi-centre, prospective, observational programme among hypertensive patients using different doses of Perindopril and Amlodipine. Primary endpoint was assessed as the change in mean sitting systolic and diastolic BPs from baseline to 3 months. Results: 937 patients (55.7% female) were analysed, and the mean age was 56.4 ± 12.7 years. Systolic and diastolic BPs were significantly reduced by 17.3/ 9.4mmHg, 21.1/10.8mmHg mmHg and 24.6/12.7mmHg at 4, 8 and 12 weeks respectively compared to baseline value (p<0.0001). Dry cough was seen in 0.64% and angioedema 0.1% of the patients. Conclusions: Perindopril plus Amlodipine SPC provided clinically meaningful BP reductions and is well tolerated in a black African population.
培哚普利加氨氯地平单片联合用药在尼日利亚的疗效和耐受性:13个城市高血压研究
背景:目前还没有大规模的研究表明单片联合(SPC)抗高血压药物在非洲黑人人群中的疗效。因此,我们评估了培哚普利加氨氯地平SPC在黑非洲患者中的降压效果和耐受性。方法:对使用不同剂量培哚普利和氨氯地平的高血压患者进行多中心、前瞻性、观察性研究。主要终点评估为平均坐位收缩压和舒张压从基线到3个月的变化。结果:937例患者(女性55.7%),平均年龄56.4±12.7岁。与基线值相比,收缩压和舒张压在4周、8周和12周分别显著降低17.3/ 9.4mmHg、21.1/10.8mmHg和24.6/12.7mmHg (p<0.0001)。干咳占0.64%,血管性水肿占0.1%。结论:培哚普利加氨氯地平SPC提供临床意义的血压降低,并且在非洲黑人人群中耐受性良好。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
12
审稿时长
7 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信